• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Improvement in parameters of hematologic and immunologic function and patient well-being in the phase III RESONATE study of Ibrutinib versus ofatumumab in patients with previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    PIIS2152265018305743.pdf
    Size:
    2.405Mb
    Format:
    PDF
    Description:
    Full text, Open Access article
    Download
    Authors
    Barrientos, J
    O'Brien, S
    Brown, J
    Kay, N
    Reddy, N
    Coutre, S
    Tam, C
    Mulligan, S
    Jaeger, U
    Devereux, S
    Pocock, C
    Robak, T
    Schuster, S
    Schuh, A
    Gill, D
    Bloor, Adrian
    Dearden, C
    Moreno, C
    Cull, G
    Hamblin, M
    Jones, J
    Eckert, K
    Solman, I
    Suzuki, S
    Hsu, E
    James, D
    Byrd, J
    Hillmen, P
    Show allShow less
    Affiliation
    Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY
    Issue Date
    2018-08-18
    
    Metadata
    Show full item record
    Abstract
    Ibrutinib compared with ofatumumab significantly improves progression-free and overall survival in patients with previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
    Citation
    Improvement in parameters of hematologic and immunologic function and patient well-being in the phase III RESONATE study of Ibrutinib versus ofatumumab in patients with previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma. 2018, Clin Lymphoma Myeloma Leuk
    Journal
    Clinical Lymphoma, Myeloma & Leukemia
    URI
    http://hdl.handle.net/10541/621302
    DOI
    10.1016/j.clml.2018.08.007
    PubMed ID
    30249389
    Type
    Article
    Language
    en
    ISSN
    2152-2669
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.clml.2018.08.007
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma.
    • Authors: Munir T, Brown JR, O'Brien S, Barrientos JC, Barr PM, Reddy NM, Coutre S, Tam CS, Mulligan SP, Jaeger U, Kipps TJ, Moreno C, Montillo M, Burger JA, Byrd JC, Hillmen P, Dai S, Szoke A, Dean JP, Woyach JA
    • Issue date: 2019 Dec
    • Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
    • Authors: Byrd JC, Brown JR, O'Brien S, Barrientos JC, Kay NE, Reddy NM, Coutre S, Tam CS, Mulligan SP, Jaeger U, Devereux S, Barr PM, Furman RR, Kipps TJ, Cymbalista F, Pocock C, Thornton P, Caligaris-Cappio F, Robak T, Delgado J, Schuster SJ, Montillo M, Schuh A, de Vos S, Gill D, Bloor A, Dearden C, Moreno C, Jones JJ, Chu AD, Fardis M, McGreivy J, Clow F, James DF, Hillmen P, RESONATE Investigators
    • Issue date: 2014 Jul 17
    • Indirect Treatment Comparisons of Ibrutinib Versus Physician's Choice and Idelalisib Plus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia.
    • Authors: Sorensen S, Wildgust M, Sengupta N, Trambitas C, Diels J, van Sanden S, Xu Y, Dorman E
    • Issue date: 2017 Jan
    • Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma.
    • Authors: O'Brien S, Hillmen P, Coutre S, Barr PM, Fraser G, Tedeschi A, Burger JA, Dilhuydy MS, Hess G, Moreno C, Cramer P, Liu E, Chang S, Vermeulen J, Styles L, Howes A, James DF, Patel K, Graef T, Valentino R
    • Issue date: 2018 Oct
    • Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open-label phase 3 study.
    • Authors: Huang X, Qiu L, Jin J, Zhou D, Chen X, Hou M, Hu J, Hu Y, Ke X, Li J, Liang Y, Liu T, Lv Y, Ren H, Sun A, Wang J, Zhao C, Salman M, Sun S, Howes A, Wang J, Wu P, Li J
    • Issue date: 2018 Apr
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.